Shanghai Vital Deeptech Clarifies: Current Core Operations Do Not Include Indium Phosphide Substrate Business

Shanghai Wanye Enterprises Logs Nearly 90% Surge in Q2 Contracted Real Estate Sales; Shares Plunge 10%

Shanghai Wanye Enterprises Controlling Shareholder Pledges Share Lock-Up on 23.85% Stake; Shares Rise 4%

Shareholders Confront Executives Over Deleted Posts and Indium Phosphide Questions Following Extreme Stock Volatility

Shanghai Vital Deeptech Executives Plan to Buy at Least 16 Million Yuan in Shares

Questions Arise Over Shanghai Vital Deeptech's 2 Billion Yuan Capital Increase: Is Zhu Shihui Repeating a Playbook of Control, Price-Lock, and Restructuring?

Concerns Raised Over Vital Deeptech's Financial Health and Corporate Governance Under New Controlling Shareholder

Shanghai Wanye Enterprises Expects Up to 464% Surge in H1 Attributable Profit

Regulators Question Potential Insider Leaks as Stock Soars Before Announcement of Related-Party Indium Phosphide Asset Acquisition

Vital Deeptech Seeks Control of Subsidiary Via Capital Injection Following Dual Limit-Up Sessions

Shanghai Vital Deeptech Plans to Acquire Controlling Stake in Subsidiary via Capital Increase

Shanghai Wanye Enterprises Says Profilometer Product Still in Early Stages; Shares Up 5%

Vital Deeptech Clarifies Non-Contact Profiler Technology Status: R&D Milestone Reached, No Orders Secured Yet

Shanghai Vital Deeptech's Contracted Sales Slid 62% in Q4 2025; Shares Rise 4%

Shanghai Vital Microtech Swings to Attributable Loss in 2025; Shares Rise 4%

China's M&A Market Leaderboard for Q1 2026

Questions Surrounding $3.51 Billion Private Placement by Vital Microtech: Controlling Shareholder Takes Discounted Shares as Major Investor Sells Off

Shanghai Vital Microtech Plans Private Share Placement to Raise Up to 3.51 Billion Yuan

BRIEF-Shanghai Vital Microtech To Raise Funds Via A-Share Private Placement

Shanghai Vital MicroTech Says It Plans to Raise up to 3.5 Bln Yuan via a-Share Private Placement to Fund Projects